Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: report of two cases

J Infect. 2000 Jan;40(1):94-6. doi: 10.1053/jinf.1999.0607.


We describe two cases of human immunodeficiency virus-infected patients with visceral leishmaniasis in whom no clinical and parasitological disease relapses were observed after liposomal amphotericin B therapy combined with potent antiretroviral treatment.

Publication types

  • Case Reports

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / parasitology
  • Adult
  • Amphotericin B / therapeutic use*
  • Anti-HIV Agents / therapeutic use*
  • Antiprotozoal Agents / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Leishmaniasis, Visceral / drug therapy*
  • Leishmaniasis, Visceral / parasitology
  • Male
  • Middle Aged
  • Remission Induction
  • Reverse Transcriptase Inhibitors / therapeutic use*


  • Anti-HIV Agents
  • Antiprotozoal Agents
  • Reverse Transcriptase Inhibitors
  • liposomal amphotericin B
  • Amphotericin B